VALORANT player profile · Asia-Pacific region · Account level 473 · Title “Fam” · 0 profile views
No ranked matches recorded for this player.
| Tracked matches | 17 |
|---|---|
| Win rate | 25.0% (2 W / 6 L over 17 matches with recorded stats) |
| K/D | 1.07 (353 kills / 331 deaths / 89 assists) |
| Average combat score | 4613 |
| Headshot rate | 20.7% |
| Date | Mode | Map | Agent | Result | K/D/A | ACS | RR |
|---|---|---|---|---|---|---|---|
| 2026-07-02 | Deathmatch | Ascent | Gekko | - | 39/20/4 | 11701 | - |
| 2026-06-30 | Deathmatch | Summit | Deadlock | - | 15/16/4 | 4821 | - |
| 2026-06-29 | Team Deathmatch | Glitch | Phoenix | L | 26/21/4 | 7548 | - |
| 2026-06-13 | Deathmatch | Fracture | Yoru | - | 28/20/3 | 8256 | - |
| 2026-06-08 | Competitive | Lotus | Phoenix | L | 13/19/7 | 163 | - |
| 2026-06-06 | Deathmatch | Pearl | Tejo | - | 19/10/2 | 5601 | - |
| 2026-06-04 | Competitive | Lotus | Phoenix | L | 17/17/5 | 194 | - |
| 2026-06-02 | Competitive | Fracture | Vyse | L | 20/16/5 | 278 | - |
| 2026-05-30 | Competitive | Fracture | Phoenix | L | 19/17/6 | 214 | - |
| 2026-05-30 | Competitive | Breeze | Omen | L | 9/17/10 | 119 | - |
| 2026-05-30 | Competitive | Ascent | Omen | W | 7/14/11 | 133 | - |
| 2026-05-30 | Deathmatch | Lotus | Killjoy | - | 21/35/3 | 6284 | - |
| 2026-05-29 | Competitive | Split | Skye | W | 13/14/8 | 163 | - |
| 2026-05-16 | Deathmatch | Fracture | Tejo | - | 33/27/2 | 10152 | - |
| 2026-05-16 | Deathmatch | Ascent | Sage | - | 38/24/6 | 11042 | - |
| 2026-05-09 | Deathmatch | Fracture | Viper | - | 13/21/4 | 4321 | - |
| 2026-05-05 | Deathmatch | Ascent | Reyna | - | 23/23/5 | 7432 | - |
31 known items (20 weapon skins), collection value roughly 29700 VP.
Notable skins: MK.VII Liberty Combat Knife, Protocol 781-A Sheriff, Nocturnum Phantom, Neo Frontier Marshal, RGX 11z Pro Vandal, Singularity Ares, Prime//2.0 Odin, Prime Spectre, Prime Guardian, Oni Bulldog, Oni Frenzy, Magepunk Operator, Sovereign Stinger, Sovereign Ghost, Prime Classic.
No penalty records for this player.